Introduction Urothelial bladder carcinoma frequently occurs in adults over 60 years of age; yet it affects only 0.1-0.4% of patients before the first 2 decades of life. We present two cases of transitional cell carcinoma in two young patients treated with holmium:YAG laser to demonstrate the effectiveness of this technique in pediatrics. Cases and methods Case study 1 During a routine abdomen ultrasound, a 14-year-old female showed a endoluminal formation about 10 × 6 × 10 mm of size, in the left paramedian site. There was an absence of meaningful vascular signs during color-Doppler. Physical examination and laboratory exams were all normal. Case study 2 A 12-year-old female presented with acute macroscopic haematuria. No other symptoms were associated. Bladder ultrasound revealed an irregular 15 mm intravesical endophytic lesion in the posterior-superior area. In both cases, treatment commenced with an en bloc enucleation. For the resections, a 272 µm holmium:YAG fiber laser was used through the 12 Ch cystoscopy working channel with an energy of 0.8-1 J/pulse and a frequency of 8-10 Hz. Results There was no haematuria after the procedure and the transurethral catheter remained for 12 h. The histological diagnosis was papillary urothelial neoplasm of low malignant potential. Cystoscopy was performed 3 and 9 months after the surgery and an ultrasound every 6 months, which all came back normal. The follow-up continued for each patient with a cystoscopy once a year, according to EAU guidelines. Conclusion Based on the findings, holmium:YAG laser is a good alternative to treat superficial transitional cell carcinoma in pediatric patients.
Introduction
Urothelial bladder carcinoma frequently occurs in adults aged over 60; yet it affects only 0.1-0.4% of patients before the first 2 decades of life [1] . In paediatric patients, it is mostly a solitary non-invasive low-grade tumour, localized in the trigone zone or ureteral orifices. Urothelial bladder carcinoma is more common in male adolescents than female adolescents. Furthermore, in adolescents, diagnosis is usually delayed due to underestimation of haematuria and to lower inclination to perform invasive procedures, requiring general anaesthesia, in young patients [1, 2] .
Various risk factors for bladder carcinoma in patients younger than 30 years have been identified. These include active and passive smoke and a familial history of bladder carcinoma [2] . Over 90% of paediatric patients present gross and painless haematuria as a primary sign. However, other symptoms such as dysuria, urgency, and frequency also occur. Whilst it is known that paediatric urothelial carcinomas have lower risks of progression, recurrence, and death; these risks do increase in patients older than 20-30 years, resulting in a worse prognosis similar to that of adults with bladder carcinoma [2] . To our knowledge, there is no evidence that urine cytology has a good sensitivity to detect low-grade tumors or papillary urothelial neoplasm of low malignant potential (PUNLMP) in pediatric patients. However, it is clear that ultrasonography (USG), together with cystoscopy, are gold standards in the diagnostic process [3] .
Nowadays, there are no standardized recommendations in the management of transitional cell carcinoma in pediatric and adolescent patients, even if the transurethral resection bladder tumor (TURBT) is always performed [4, 5] . There are three different types of the TURBT surgical technique. These include the conventional monopolar (CM-TURBT), plasmakinetic (PK-TURBT) and holmium laser (HoL-TURBT) [5] [6] [7] . The last two might be preferable alternatives to CM-TURBT since they rarely lead to bladder perforation and other complications that might occur in the conventional monopolar resection [6] [7] [8] . However, they have no advantage in terms of tumor recurrence rate. Whilst for the CMand PK-TURBT, a piece-by-piece resection of the neoplasm is performed; for the HoL-TURBT, an en bloc cut is rapidly executed to keep from the alteration of the postoperative pathological examination [5] [6] [7] [8] [9] . This latter technique offers three advantages: it improves the resection quality, lowers the perioperative complications rates, and decreases recurrence rates [9] . This paper presents our successful experience using HoL-TURBT to treat bladder TCC in two paediatric patients and aims to demonstrate the effectiveness of this innovative technique.
Cases and methods

Case 1
The first case is a 14-year-old female who was being treated for an eating disorder in the Child and Adolescent Psychiatry Department at Bambino Gesù Children Hospital. During a routine follow-up, the abdominal USG showed a spaceoccupying lesion (SOL) about 10 mm of size ( Fig. 1a ) in the left paramedian site. Furthermore, there was an absence of meaningful vascular signs during colour-Doppler. Active smoking was detected as a risk factor for bladder tumour in this case.
After 3 months, the patient repeated an USG which indicated enhanced growth of the SOL. She did not report urinary burning or gross haematuria. On November 2016, 4 months after the first USG, an en bloc resection of the neoplasm using holmium laser was performed. Deep biopsy of the resected area was conducted to exclude muscle or lamina propria involvement. At pathology, histological diagnosis of PUNLMP, was confirmed.
Case 2
The second case is a 12-year-old female who presented with an episode of gross hematuria and dysuria at the Department of Pediatric Urology at Bambino Gesù Children Hospital. Consequently, we performed a kidney and bladder ultrasound that indicated a 15 mm diameter SOL in the posterior bladder wall (Fig. 1b) . No risk factors for bladder tumours were detected in this case.
On February 2018, 1 month after the first USG, an en bloc resection of the SOL using holmium laser was performed. Deep biopsy of the resected area was conducted to exclude muscle or lamina propria involvement. Histological diagnosis of PUNLMP was made.
Equipment and follow-up procedures
The equipment used included a holmium:YAG fiber laser of 272 µm in diameter through the 12 Ch cystoscopy working channel with an energy of 0.8-1 J/pulse and a frequency of [8] [9] [10] Hz. During the procedure, patients were maintained in the lithotomy position. After the resection, a selective biopsy of bladder wall was performed (Fig. 2 ). There was not hematuria after the procedure and the transurethral catheter remained for 12 h.
The mean follow-up time for the patients was 2.5 years (2-3 years). During the follow-up, cystoscopy and USG were performed. In accordance with the European Association of Urology (EAU) guidelines on non-muscular invasive bladder cancer (NMIBC), cystoscopy was done at 3 months and then at 9 months in the first year. This was followed by an annual cystoscopy for a further 4 years. Additionally, the patients were examined using USG with the same schedule of the cystoscopy. At 2-year follow-up, no recurrence was found among the patients.
Discussion
Urothelial bladder cancer was described in less than 150 patients younger than 18 years of age and in less than 30 patients in the first decades of life; as such, it is extremely rare in pediatric patients [1] . Urothelial neoplasms have a great genetic stability, low incidence of invasiveness, and a great overall and disease-free survival in younger patients [1] [2] [3] .
However, the diagnosis is sometimes delayed due to the predominance of hematuria's benign causes in this age group. Differential diagnosis includes blood clots on the bladder wall and genitourinary rhabdomyosarcoma, which is a soft tissue tumor that can affect children, with 15-20% of it arising from genitourinary tract [10] .
Research indicates that hematuria is the most common presenting symptom, even if, in some cases, abdominal pain and dysuria are present [3] . Only in one of our cases the main symptom was hematuria.
Ultrasonography is the first diagnostic investigation performed proving to be specific, without false positives and capable of detecting lesions as small as 5 mm. Cystoscopy is usually performed to confirm the presence of the tumor [5] . In the reported cases, to avoid the need for a second anaesthesia, we performed LASER en bloc resection during the diagnostic cystoscopy.
While CM-TURBT is the first-choice treatment of superficial bladder tumors [5, 6] , it has been associated with significant complications such as bleeding, bladder perforation, obturator nerve reflex, and bladder explosion [6] . Moreover, the aim of TURBT is not just to remove the tumour but also to provide adequate tissue for accurate diagnosis and staging during pathologic investigation. Specifically, the removed specimen should contain detrusor muscle to allow the pathologist to assess whether the tumour had invaded the muscle. However, electric cauterization in the CM-TURBT could destroy the specimens' bottom tissue leading to inadequate tissue for pathologic investigation [5] [6] [7] . Additionally, the risk of destroying the specimen's bottom tissue is enhanced in children and adolescents, as the detrusor is thinner than in adults. As such, the CM-TURBT can be deemed an excessively invasive technique to treat small superficial bladder tumours, given the characteristics of both the tumour and the patients [11] .
To solve these issues related to TURBT, new types of surgical laser procedures have emerged [12] .
The neodymium:YAG laser was the first to be used, but it had to be abandoned when complications, such as severe intestinal perforation, were reported [12, 13] .The holmium:YAG laser we used has a wavelength of 2 100 nm which gives it a special affinity for blood and water. The temperature required to produce irreversible tissue alterations, due to proteins' denaturation, is 60-100 °C and vaporization occurs at temperatures above 100 °C [12] . This temperature is difficult to reach in the bladder environment since it is surrounded by fluids, which defines the holmium:YAG laser at a penetration depth of 0.5-1.0 mm, greatly limiting the chances of severe complications. This laser has many advantages in reducing intra-and postoperative complications, postoperative bladder irrigation, shortening postoperative catheterization, and hospitalization time [6, 7] . Our patients had no postoperative hematuria and removed the catheter after 12 h, with 1 day of hospitalization using this innovative laser technique.
With the incidence and the recurrence rate (about 7%) of pediatric urothelial carcinoma being low, there is no standardised protocol for the follow-up [3] . In 2015, Berrettini et al. stated that cystoscopy is too invasive to be performed in the follow-up protocol since it requires general anesthesia in children. For this reason, they proposed only the USG as a method for the surveillance [14] . The same proposal was done in 2016 by Polat et al. [15] . However, Marinoni et al. preferred, as a follow-up, cystoscopies after 3 and 12 months together with USG [16] . According to this latter study, the USG surveillance should be continued for 5 years and the cystoscopy should be proposed, after the first year, only if the ultrasounds came back positive for recurrence. In all the previous studies known to us, it is shown that urine cytology is unnecessary since the pediatric bladder lesions are mostly benign and that USG is a gold standard to detect recurrent lesions due to its high sensitivity [14] [15] [16] .
Based on the EAU guidelines regarding "Non-Muscle Invasive Bladder Cancer", we decided to do a follow-up consisting of a cystoscopy at month 3, since it is an important prognostic indicator for recurrence and progression in adults, and another one at month 9. The cystoscopy continued to be performed once a year, even if invasive, considering that these pediatric neoplasms are of a low risk [17] . Together with this follow-up procedure, we also performed USG at months 6 and 12.
Conclusion
Based on the above case studies, the holmium:YAG laser is a good alternative to treat superficial transitional cell carcinoma. This laser has many advantages, compared to the older ones, in reducing intra-and post-operative complications, postoperative bladder irrigation, shortening postoperative catheterization, and hospitalization time. Our patients had no postoperative hematuria and removed the catheter after 12 h, with 1 day of hospitalization.
